OSURNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

ORASURE TECHNOLOGIES INC

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026

$3.68+0.07 (+1.94%)

Close on Oct 19, 2026

Market cap: $258.18M
P/E (TTM): –
Dividend yield: –

ORASURE TECHNOLOGIES INC income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	Q2 2026 2026-06-30	Q1 2026 2026-03-31	Q4 2025 2025-12-31	Q3 2025 2025-09-30	Q2 2025 2025-06-30	Q1 2025 2025-03-31	Q4 2024 2024-12-31	Q3 2024 2024-09-30	Q2 2024 2024-06-30	Q1 2024 2024-03-31	Q4 2023 2023-12-31	Q3 2023 2023-09-30	Q2 2023 2023-06-30	Q1 2023 2023-03-31	Q4 2022 2022-12-31	Q3 2022 2022-09-30	Q2 2022 2022-06-30	Q1 2022 2022-03-31	Q4 2021 2021-12-31	Q3 2021 2021-09-30	Q2 2021 2021-06-30	Q1 2021 2021-03-31	Q4 2020 2020-12-31	Q3 2020 2020-09-30	Q2 2020 2020-06-30	Q1 2020 2020-03-31	Q4 2019 2019-12-31	Q3 2019 2019-09-30	Q2 2019 2019-06-30	Q1 2019 2019-03-31	Q4 2018 2018-12-31	Q3 2018 2018-09-30	Q2 2018 2018-06-30	Q1 2018 2018-03-31	Q4 2017 2017-12-31	Q3 2017 2017-09-30	Q2 2017 2017-06-30	Q1 2017 2017-03-31	Q4 2016 2016-12-31	Q3 2016 2016-09-30
Revenue	31	28	27	27	31	30	37	40	54	54	76	89	85	155	123	116	80	68	64	54	58	59	63	48	29	32	50	36	39	30	50	46	44	42	52	42	40	33	35	32
Cost of Revenue	17	16	16	15	18	18	24	23	30	30	41	45	59	89	73	70	52	43	36	32	27	20	25	18	12	15	20	14	14	12	16	17	18	18	24	18	15	12	12	9.58
Gross Profit	13	12	11	12	13	12	14	17	25	24	35	44	26	66	50	47	28	24	27	21	31	38	38	30	17	16	30	22	25	18	35	29	26	24	29	25	25	20	24	23
Research & Development	9.44	14	11	10	11	9.60	6.09	5.62	6.60	7.74	6.99	8.52	7.66	11	8.05	10	9.46	8.63	8.90	8.60	7.68	8.99	10	8.01	6.92	5.64	6.10	4.62	4.54	4.37	4.06	3.86	4.26	4.08	3.83	3.23	3.34	2.97	1.21	3.20
Selling, General & Admin	21	21	16	17	19	21	20	17	20	20	21	19	25	30	27	29	29	32	28	26	21	20	21	18	20	17	19	17	15	16	18	14	16	21	15	14	15	14	16	13
Selling & Marketing	6.60	6.77	6.58	6.30	6.38	6.86	6.99	7.62	7.93	8.45	6.91	8.74	8.54	12	11	13	12	13	11	14	10	9.53	9.12	7.85	10	7.37	7.93	8.96	7.69	7.30	8.38	7.30	7.43	7.50	6.99	7.16	7.50	6.88	7.12	6.43
General & Administrative	14	15	9.82	11	13	14	13	9.83	12	12	14	10	16	18	16	16	18	19	17	12	11	10	12	10	10	10	12	7.56	7.26	8.93	9.76	6.53	8.65	13	7.54	6.94	7.75	7.09	8.55	6.91
Operating Expenses	7.88	35	31	28	31	30	26	23	27	31	31	33	33	41	35	46	49	40	37	34	29	28	30	26	27	24	26	8.59	20	22	22	18	20	25	18	17	19	4.44	17	17
Total Costs & Expenses	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	46	23	34	34	38	35	38	42	42	35	33	17	28	26
Operating Income	5.44	-23	-20	-16	-18	-18	-12	-6.00	-2.74	-7.09	3.90	11	-6.43	24	15	0.87	-21	-16	-9.37	-13	1.80	10	7.89	4.39	-9.40	-8.05	4.09	13	5.29	-3.81	13	11	5.56	-0.50	10	7.32	6.89	16	7.07	6.14
Interest & Investment Income	1.21	1.22	1.80	2.05	2.07	2.16	2.53	2.89	3.03	3.02	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Income from Equity Investments	-0.51	-1.09	-0.64	-0.37	-0.80	-0.52	-0.53	-0.61	-0.56	0	0	0	0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Other Non-Operating Income	0.24	0.17	0.09	0.15	0	-0.02	-0.72	0.10	-0.04	0.27	11	2.61	1.47	2.67	-2.01	3.59	1.71	0.17	0.44	0.10	0.45	-0.12	-0.31	0.31	0.22	1.43	0.48	1.20	0.52	0.52	1.63	0.51	0.74	0.41	0.12	0.11	0.10	0.47	0.09	0.50
Asset Impairment Charges	–	–	0	0	0	0	0	0	1.05	3.34	3.33	6.18	0.22	1.11	0	6.56	3.60	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Gain (Loss) on Sale of Assets	0.02	0	-0.27	0	0	0.99	0	0	0	0	0	0	–	–	0	-0.01	-0.01	-0.71	–	–	–	–	-0.01	–	–	–	0.00	10	–	–	–	–	–	–	–	–	–	–	–	–
Legal Settlements	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0	0	0	13	–	–
Pretax Income	6.82	-22	-18	-13	-17	-16	-9.51	-3.22	0.33	-3.60	21	14	-4.96	27	16	4.45	-20	-16	-8.93	-13	2.25	10	7.58	4.70	-9.19	-6.62	4.56	14	5.81	-3.29	14	11	6.29	-0.09	10	7.43	6.98	16	7.17	6.64
Income Tax Expense	0.06	-0.43	0.21	0.05	2.00	-0.46	0.76	0.68	0.38	-0.02	0.65	2.35	-0.17	-0.23	-0.17	-1.14	-1.17	3.94	1.47	2.10	3.61	6.53	5.72	3.66	1.31	0.71	2.12	1.17	1.41	-0.03	3.84	3.27	2.17	2.03	2.96	1.67	1.56	3.90	-0.03	0.40
Net Income incl. Noncontrolling Interests	–	–	–	–	–	–	–	–	–	–	–	–	–	27	16	5.27	-19	-20	-10	-15	-1.36	3.77	1.86	1.04	-10	-7.33	2.44	13	4.40	-3.26	10	8.10	4.12	-2.12	7.32	5.76	–	–	–	–
Net Income	6.25	-22	-19	-14	-20	-16	-11	-4.51	-0.62	-3.58	20	11	-4.80	27	16	5.60	-19	27	-10	-15	-1.36	3.77	1.86	1.04	-10	-7.33	2.44	13	4.40	-3.26	10	8.10	4.12	-2.12	7.32	5.76	5.43	12	7.20	6.24
EPS (Basic)(per share)	0.09	-0.32	-0.27	-0.19	-0.26	-0.21	-0.14	-0.06	-0.01	-0.05	0.27	0.15	-0.07	0.37	0.22	0.08	-0.26	-0.28	-0.14	-0.21	-0.02	0.05	–	0.01	-0.16	-0.12	0.04	0.21	0.07	-0.05	0.17	0.13	0.07	-0.03	0.12	0.10	0.09	0.22	0.13	0.11
EPS (Diluted)(per share)	0.09	-0.32	-0.27	-0.19	-0.26	-0.21	-0.14	-0.06	-0.01	-0.05	0.27	0.15	-0.07	0.37	0.22	0.08	-0.26	-0.28	-0.14	-0.21	-0.02	0.05	–	0.01	-0.16	-0.12	0.04	0.21	0.07	-0.05	0.16	0.13	0.07	-0.03	0.12	0.09	0.09	0.21	0.13	0.11
Shares Outstanding (Basic, Weighted)(shares)	69	70	72	73	75	75	75	75	74	74	73	73	73	73	73	73	72	72	72	72	72	72	72	72	65	62	62	62	62	62	61	61	61	61	61	60	58	57	56	56
Shares Outstanding (Diluted, Weighted)(shares)	70	70	72	73	75	75	75	75	74	74	75	74	73	74	73	73	72	72	72	72	72	73	72	73	65	62	62	62	62	62	63	63	62	61	62	62	61	59	57	57
EBITDA	7.81	-21	-18	-14	-16	-15	-9.93	-2.95	-0.13	-4.37	7.46	14	3.89	28	19	4.79	-18	-12	-6.19	-9.68	4.45	13	10	6.77	-7.07	-5.88	5.89	15	7.17	-2.09	13	13	7.44	1.37	12	9.02	8.36	17	8.61	7.56

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 42.6%
Operating margin: -48.1%
Net margin: -43.7%
Return on equity, FY2025: -18.3%

Financial strength

Current ratio: 8.88
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 639.3%

Valuation

P/E ratio: –
Price to sales: 2.30
Price to book: 0.81
Dividend yield: –